Growth Metrics

Profound Medical (PROF) Other Non-Current Liabilities (2018 - 2026)

Profound Medical's quarterly Other Non-Current Liabilities came in at $92000.0 in Q1 2026, up 27.78% year-on-year from $72000.0 in Q1 2025, and up 16.46% quarter-over-quarter from $79000.0 in Q4 2025.

Profound Medical has reported Other Non-Current Liabilities for 7 years, with the latest figure at $92000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Other Non-Current Liabilities rose 27.78% year-over-year to $92000.0; the trailing twelve-month figure through Mar 2026 stood at $92000.0 (up 27.78% YoY), and the FY2025 full-year result was $79000.0, up 11.27% from the prior year.
  • Other Non-Current Liabilities for Q1 2026 stood at $92000.0, up from $79000.0 in the prior quarter.
  • The five-year high for Other Non-Current Liabilities was $92000.0 in Q1 2026, with the low at $71000.0 in Q4 2024.
  • Average Other Non-Current Liabilities over 4 years is $75800.0, with a median of $73500.0 recorded in 2023.
  • Year-over-year, Other Non-Current Liabilities declined 2.74% in 2024 and gained 27.78% in 2026.
  • Tracing PROF's Other Non-Current Liabilities over 4 years: stood at $73000.0 in 2023, then decreased by 2.74% to $71000.0 in 2024, then rose by 11.27% to $79000.0 in 2025, then grew by 16.46% to $92000.0 in 2026.
  • The last three Other Non-Current Liabilities figures came in at $92000.0 (Q1 2026), $79000.0 (Q4 2025), and $76000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Profound Medical 244.28 Mn 193.99 Mn 3.83 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 92,000.00
Dec 31, 2025 79,000.00
Sep 30, 2025 76,000.00
Jun 30, 2025 77,000.00
Mar 31, 2025 72,000.00
Dec 31, 2024 71,000.00
Sep 30, 2024 74,000.00
Jun 30, 2024 72,000.00
Mar 31, 2024 72,000.00
Dec 31, 2023 73,000.00
Dec 31, 2020 75.94
Sep 30, 2020 79,000.00
Jun 30, 2020 78,000.00
Mar 31, 2020 150,000.00
Dec 31, 2019 217,294.46
Sep 30, 2019 651,170.00
Dec 31, 2018 757,735.71